- Home
- VTR vs WAT Comparison
VTR vs WAT Comparison
Compare VTR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTR
- WAT
- Stock Information
- Founded
- VTR 1983
- WAT 1958
- Country
- VTR United States
- WAT United States
- Employees
- VTR N/A
- WAT N/A
- Industry
- VTR Real Estate Investment Trusts
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- VTR Real Estate
- WAT Industrials
- Exchange
- VTR Nasdaq
- WAT Nasdaq
- Market Cap
- VTR 27.3B
- WAT 22.5B
- IPO Year
- VTR 1998
- WAT 1995
- Fundamental
- Price
- VTR $61.76
- WAT $388.06
- Analyst Decision
- VTR Buy
- WAT Hold
- Analyst Count
- VTR 10
- WAT 13
- Target Price
- VTR $60.40
- WAT $363.92
- AVG Volume (30 Days)
- VTR 2.6M
- WAT 538.6K
- Earning Date
- VTR 10-30-2024
- WAT 11-01-2024
- Dividend Yield
- VTR 2.90%
- WAT N/A
- EPS Growth
- VTR N/A
- WAT N/A
- EPS
- VTR N/A
- WAT 10.48
- Revenue
- VTR $4,797,115,000.00
- WAT $2,905,147,000.00
- Revenue This Year
- VTR N/A
- WAT $0.53
- Revenue Next Year
- VTR $7.07
- WAT $5.59
- P/E Ratio
- VTR N/A
- WAT $37.36
- Revenue Growth
- VTR 10.05
- WAT N/A
- 52 Week Low
- VTR $41.45
- WAT $279.24
- 52 Week High
- VTR $67.61
- WAT $395.44
- Technical
- Relative Strength Index (RSI)
- VTR 37.74
- WAT 60.79
- Support Level
- VTR $61.73
- WAT $380.14
- Resistance Level
- VTR $65.24
- WAT $395.39
- Average True Range (ATR)
- VTR 0.97
- WAT 10.96
- MACD
- VTR -0.26
- WAT 1.00
- Stochastic Oscillator
- VTR 4.92
- WAT 86.54
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.